U.S. Markets closed
  • 2 Big Dividend Stocks Yielding at Least 8%; Analysts Say ‘Buy’
    Business
    TipRanks

    2 Big Dividend Stocks Yielding at Least 8%; Analysts Say ‘Buy’

    There’s an old saying in the markets that you should ‘sell in May and go away.’ It’s a reference to long-noticed trend of summertime swoons, when market trading slows, or even dips, especially in August. Recent statistical research by CFRA research has quantified the phenomenon. Since 1945, they say, August is the year’s third-worst month for returns on the S&P 500, on average. The trend is particularly marked in years when the index set record high levels in July. A report from LPL Financial ad

  • How about genuine reform of capital-gains tax rates?
    Business
    MarketWatch

    How about genuine reform of capital-gains tax rates?

    Biden would set the rate way too high, but there is an ideal way to collect some revenue without killing innovation or growth

  • Wealthy Clients Clamor for Backdoor Roth IRAs. Advisors May Want to Keep that Door Shut.
    Business
    Barrons.com

    Wealthy Clients Clamor for Backdoor Roth IRAs. Advisors May Want to Keep that Door Shut.

    Headlines about PayPal founder Peter Thiel’s $5 billion tax-free retirement account have some clients salivating. But regulatory changes may be coming.

  • 2 Biotech Stocks With Big FDA Decisions in August
    Business
    TipRanks

    2 Biotech Stocks With Big FDA Decisions in August

    The biotech sector is famously volatile. Medical and pharmaceutical research involved both high overheads and years-long lead times, a combination that requires investors to be patient and to count on time frames that can sometimes reach a decade or more. But once a biotech gets a new medication onto the market, meeting a need for a substantial patient base, it’s all win – a combination of finding the Holy Grail and hitting the Powerball. It doesn’t always happen that way, however – so investors